| Lavette Goodman Graham, | |
|
1133 South Blvd Apt 605, Oak Park, IL 60302-3278 | |
| (201) 616-8181 | |
| Not Available |
| Full Name | Lavette Goodman Graham |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Psychiatric/mental Health |
| Location | 1133 South Blvd Apt 605, Oak Park, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740915677 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Lavette Goodman Graham, 1133 South Blvd Apt 605, Oak Park, IL 60302-3278 Ph: (201) 616-8181 | Lavette Goodman Graham, 1133 South Blvd Apt 605, Oak Park, IL 60302-3278 Ph: (201) 616-8181 |
News Archive
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that it has raised $33.9 million in a Series B funding round, led by new investor, New Enterprise Associates ("NEA"), one of the world's leading venture capital firms. Existing investor, Sofinnova Partners, also participated in the financing.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold.
Massachusetts General Hospital (MGH) researchers and their colleagues have used digital versions of a standard molecular biology tool to detect a common tumor-associated mutation in the cerebrospinal fluid (CSF) of patients with brain tumors. In their report being published in the open-access journal Molecular Therapy - Nucleic Acids, the investigators describe using advanced forms of the gene-amplification technology polymerase chain reaction (PCR) to analyze bits of RNA carried in membrane-covered sacs called extracellular vesicles for the presence of a tumor-associated mutation in a gene called IDH1.
› Verified 8 days ago
Kristen Bryan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 344 S Maple Ave Apt 1b, Oak Park, IL 60302 Phone: 405-420-5091 | |
Mrs. Katlyn Poupore, R.N. Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3 Erie Ct, Oak Park, IL 60302 Phone: 708-763-6747 | |
Mrs. Nicole K Schnoes, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3 Erie Ct, Oak Park, IL 60302 Phone: 708-763-6747 | |
Caitlin Mcginness, Registered Nurse Medicare: Medicare Enrolled Practice Location: 610 S Maple Ave Ste 5500, Oak Park, IL 60304 Phone: 708-660-2328 | |
Nancy Jane O'connell, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 120 S Marion St, Oak Park, IL 60302 Phone: 708-383-7500 Fax: 708-383-7780 | |
Chris Lati, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1025 S Harvey Ave, Oak Park, IL 60304 Phone: 708-287-0968 | |
Ms. Tanya C Mchale, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 715 Lake St, Suite 516, Oak Park, IL 60301 Phone: 708-725-3025 Fax: 708-848-3031 |